Answers are grounded in this paper and cite their sources.
The extracellular matrix (ECM) provides structural support and mechanical signals that regulate cell behavior. Disease-related ECM remodeling can alter tissue mechanics and activate cellular responses that further promote pathological matrix deposition or degradation, creating a self-reinforcing feedback loop. This review compares ECM mechanical remodeling across chronic lung disease, cancer, arthritis, cardiovascular disease, and neurodegenerative disease. Although tissue stiffening is common in fibrosis and cancer, other conditions show regional softening or altered time-dependent behavior. These differences reflect tissue-specific changes in matrix composition and organization. Cells sense the remodeled ECM through adhesion complexes, mechanosensitive ion channels, and YAP/TAZ-related signaling, but the resulting effects depend on cell type and disease stage. Mechanical measurements are also influenced by the method and spatial scale used, which limits direct comparison among studies. Current therapeutic strategies aim to modify the matrix or disrupt abnormal mechanotransduction, but evidence that these approaches restore tissue mechanics remains limited. A better understanding of spatial and temporal mechanical changes may support more precise ECM-targeted therapies.
No takes yet. Share an insight, caveat, or question.
Qian et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: